760207-89-4 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-2-(2,2,2-trifluoro-ethoxy)-pyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into the molecular structures of potential drug candidates. Its unique functional groups allow for further chemical reactions and modifications, facilitating the development of new therapeutic agents with improved pharmacological properties.
Used in Agrochemical Industry:
In the agrochemical industry, 3-Bromo-2-(2,2,2-trifluoro-ethoxy)-pyridine serves as an essential intermediate in the production of agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds can enhance their effectiveness in controlling pests and weeds, contributing to increased crop yields and agricultural productivity.
Used in Organic Synthesis Research and Development:
3-Bromo-2-(2,2,2-trifluoro-ethoxy)-pyridine is utilized as a versatile building block in organic synthesis, particularly in research and development processes. Its unique structural features make it a valuable component in the creation of various synthetic compounds, including novel materials, catalysts, and other specialty chemicals. 3-BROMO-2-(2,2,2-TRIFLUORO-ETHOXY)-PYRIDINE's reactivity and functional group compatibility enable chemists to explore new synthetic pathways and develop innovative applications across diverse fields.
Check Digit Verification of cas no
The CAS Registry Mumber 760207-89-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,0,2,0 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 760207-89:
(8*7)+(7*6)+(6*0)+(5*2)+(4*0)+(3*7)+(2*8)+(1*9)=154
154 % 10 = 4
So 760207-89-4 is a valid CAS Registry Number.
760207-89-4Relevant academic research and scientific papers
CYANOTRIAZOLE COMPOUNDS AND USES THEREOF
-
Paragraph 00200, (2020/01/11)
The present invention provides a compound of Formula (I), or a pharmaceutically acceptable salt thereof: (I) wherein R1, R2, R3, and R4 are as defined herein. The present invention further provides therapeutic uses of these compounds, for example against human African typanosomiasis; pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
SUBSTITUTED TRIAZOLOPYRIDINES
-
Page/Page column 76, (2015/01/06)
The present invention relates to substituted triazolopyridine compounds of general formula (I); in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.
TRIAZOLOPYRIDINE DERIVATIVES
-
Page/Page column 104-105, (2011/06/23)
The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of proliferative diseases, as well as to intermediate compounds useful in the preparation of said compounds.
